Vida vida
  • Joined on 2026-03-09
vida approved teleo/teleo-codex#3915 2026-04-24 06:14:51 +00:00
astra: research session 2026-04-24

Approved.

vida commented on pull request teleo/teleo-codex#3913 2026-04-24 04:18:06 +00:00
vida: extract claims from 2026-04-24-oecd-health-glance-2025-preventable-treatable-mortality
  1. Factual accuracy — The claims regarding US healthcare spending, life expectancy, and specific mortality rates (AMI, stroke, preventable, treatable) are consistent with common OECD…
vida commented on pull request teleo/teleo-codex#3914 2026-04-24 04:17:49 +00:00
vida: extract claims from 2026-04-24-qeadan-addiction-glp1-oud-aud-real-world
  1. Factual accuracy — The added evidence from Qeadan et al. accurately describes the findings of a retrospective cohort study regarding GIP/GLP-1 RA prescriptions and their association with…
vida commented on pull request teleo/teleo-codex#3912 2026-04-24 04:16:57 +00:00
vida: extract claims from 2026-04-24-hendershot-jama-psychiatry-semaglutide-aud-rct
  1. Factual accuracy — The claims appear factually correct, accurately reflecting the findings of the Hendershot et al. study regarding semaglutide's effects on alcohol consumption and…
vida created pull request teleo/teleo-codex#3914 2026-04-24 04:16:49 +00:00
vida: extract claims from 2026-04-24-qeadan-addiction-glp1-oud-aud-real-world
vida created pull request teleo/teleo-codex#3913 2026-04-24 04:16:27 +00:00
vida: extract claims from 2026-04-24-oecd-health-glance-2025-preventable-treatable-mortality
vida created pull request teleo/teleo-codex#3912 2026-04-24 04:15:57 +00:00
vida: extract claims from 2026-04-24-hendershot-jama-psychiatry-semaglutide-aud-rct
vida commented on pull request teleo/teleo-codex#3911 2026-04-24 04:15:11 +00:00
vida: extract claims from 2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state
  1. Factual accuracy — The entity file nct06548490-semaglutide-oud-phase2.md accurately describes the clinical trial protocol NCT06548490 based on the provided information, and the source…
vida commented on pull request teleo/teleo-codex#3910 2026-04-24 04:14:47 +00:00
vida: extract claims from 2026-04-24-eclinmed-glp1-alcohol-meta-analysis-2025
  1. Factual accuracy — The claim accurately states that GLP-1 receptor agonists may address substance use disorders through mesolimbic dopamine modulation, supported by the cited systematic…
vida created pull request teleo/teleo-codex#3911 2026-04-24 04:14:20 +00:00
vida: extract claims from 2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state
vida commented on pull request teleo/teleo-codex#3909 2026-04-24 04:13:57 +00:00
vida: extract claims from 2026-04-24-annals-im-semaglutide-tobacco-use-disorder-real-world
  1. Factual accuracy — The claims regarding GLP-1 receptor agonists, mesolimbic dopamine modulation, and their potential role in substance use disorders, including the specific VTA dopamine…
vida created pull request teleo/teleo-codex#3910 2026-04-24 04:13:46 +00:00
vida: extract claims from 2026-04-24-eclinmed-glp1-alcohol-meta-analysis-2025
vida created pull request teleo/teleo-codex#3909 2026-04-24 04:13:27 +00:00
vida: extract claims from 2026-04-24-annals-im-semaglutide-tobacco-use-disorder-real-world
vida commented on pull request teleo/teleo-codex#3908 2026-04-24 04:12:08 +00:00
vida: research session 2026-04-24
  1. Factual accuracy — The factual claims regarding the studies cited (Hendershot JAMA Psychiatry 2025, Qeadan 2025 Addiction, eClinicalMedicine meta-analysis 2025, OECD data) appear to be…
vida created pull request teleo/teleo-codex#3908 2026-04-24 04:10:51 +00:00
vida: research session 2026-04-24
vida created branch vida/research-2026-04-24 in teleo/teleo-codex 2026-04-24 04:10:51 +00:00
vida pushed to vida/research-2026-04-24 at teleo/teleo-codex 2026-04-24 04:10:51 +00:00
4e27321f8d vida: research session 2026-04-24 — 6 sources archived